These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Identifying predictive factors for posttransplant lymphoproliferative disease in pediatric solid organ transplant recipients with Epstein-Barr virus viremia. Weintraub L; Weiner C; Miloh T; Tomaino J; Joashi U; Benchimol C; Strauchen J; Roth M; Wistinghausen B J Pediatr Hematol Oncol; 2014 Nov; 36(8):e481-6. PubMed ID: 24878618 [TBL] [Abstract][Full Text] [Related]
5. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Allen UD; Preiksaitis JK; Clin Transplant; 2019 Sep; 33(9):e13652. PubMed ID: 31230381 [TBL] [Abstract][Full Text] [Related]
6. Post-transplant lymphoproliferative disease after pediatric kidney transplant. Fulchiero R; Amaral S Front Pediatr; 2022; 10():1087864. PubMed ID: 36568415 [TBL] [Abstract][Full Text] [Related]
7. A multicenter survey on post-transplant lymphoproliferative disorders in pediatric heart transplant recipients: A case for development of consensus guidelines for screening, surveillance, and treatment? Weisert M; Harake D; Hede S; Russell M; Alejos J; Menteer J Pediatr Transplant; 2020 Aug; 24(5):e13730. PubMed ID: 32416037 [TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation reveals differences in the tumor microenvironment. Overkamp M; Granai M; Bonzheim I; Steinhilber J; Schittenhelm J; Bethge W; Quintanilla-Martinez L; Fend F; Federmann B Virchows Arch; 2021 Jun; 478(6):1135-1148. PubMed ID: 33324999 [TBL] [Abstract][Full Text] [Related]
9. Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients. Colombini E; Guzzo I; Morolli F; Longo G; Russo C; Lombardi A; Merli P; Barzon L; Murer L; Piga S; Ciofi Degli Atti ML; Locatelli F; Dello Strologo L Pediatr Nephrol; 2017 Aug; 32(8):1433-1442. PubMed ID: 28280938 [TBL] [Abstract][Full Text] [Related]
10. Analysis of Post-Transplant Lymphoproliferative Disorder (PTLD) Outcomes with Epstein-Barr Virus (EBV) Assessments-A Single Tertiary Referral Center Experience and Review of Literature. Lau E; Moyers JT; Wang BC; Jeong ISD; Lee J; Liu L; Kim M; Villicana R; Kim B; Mitchell J; Kamal MO; Chen CS; Liu Y; Wang J; Chinnock R; Cao H Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33669937 [TBL] [Abstract][Full Text] [Related]
11. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56 Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS Front Immunol; 2020; 11():1231. PubMed ID: 32625211 [TBL] [Abstract][Full Text] [Related]
13. A single-center experience of post-transplant lymphoproliferative disorder (PTLD) cases after pediatric liver transplantation: Incidence, outcomes, and association with food allergy. Barış Z; Özçay F; Yılmaz Özbek Ö; Haberal N; Sarıalioğlu F; Haberal M Turk J Gastroenterol; 2018 May; 29(3):354-360. PubMed ID: 29755021 [TBL] [Abstract][Full Text] [Related]
14. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Styczynski J; Gil L; Tridello G; Ljungman P; Donnelly JP; van der Velden W; Omar H; Martino R; Halkes C; Faraci M; Theunissen K; Kalwak K; Hubacek P; Sica S; Nozzoli C; Fagioli F; Matthes S; Diaz MA; Migliavacca M; Balduzzi A; Tomaszewska A; Camara Rde L; van Biezen A; Hoek J; Iacobelli S; Einsele H; Cesaro S; Clin Infect Dis; 2013 Sep; 57(6):794-802. PubMed ID: 23771985 [TBL] [Abstract][Full Text] [Related]
15. Posttransplantation lymphoproliferative disorder after pediatric solid organ transplantation: experiences of 20 years in a single center. Jeong HJ; Ahn YH; Park E; Choi Y; Yi NJ; Ko JS; Min SI; Ha JW; Ha IS; Cheong HI; Kang HG Korean J Pediatr; 2017 Mar; 60(3):86-93. PubMed ID: 28392824 [TBL] [Abstract][Full Text] [Related]
16. Post-Transplant Lymphoproliferative Diseases in Pediatric Kidney Allograft Recipients with Epstein-Barr Virus Viremia. Hyun H; Park E; Cho M; Min SI; Ha J; Kang HJ; Shin HY; Ha IS; Cheong HI; Ahn YH; Kang HG J Korean Med Sci; 2019 Aug; 34(30):e203. PubMed ID: 31373185 [TBL] [Abstract][Full Text] [Related]